Matthew R. Patterson, Chief Executive Officer at Audentes Therapeutics, Inc. (BOLD), sold 14,426 shares at $30.00 ($433K) on 2019-11-08, disclosed to the SEC on 2019-11-12.
Open-market sale of $433k BOLD by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BOLD | SELL | 2018-10-02 | $1.6M | — | Filing → |
| BOLD | SELL | 2018-09-20 | $518K | — | Filing → |
| BOLD | SELL | 2018-07-05 | $5.6M | — | Filing → |